Abstract
CXL can be efficaciously performed outside of the Operating Rooms (ORs), ideally at the slit lamp. This approach could take numerous advantages, as it lowers costs and brings CXL technology away from ORs. This chapter discusses how CXL technology can be safely incorporated into the medical office, respecting indications, in remote areas where an OR is not available or in large centers where the efficiency and costs can be optimized.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Randleman JB, Khandelwal SS, Hafezi F. Corneal cross-linking. Surv Ophthalmol. 2015;60(6):509–23.
Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620–7.
Tabandeh H, Boscia F, Sborgia A, et al. Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting. Retina. 2014;34(1):18–23.
Ianchulev T, Litoff D, Ellinger D, Stiverson K, Packer M. Office-based cataract surgery: population health outcomes study of more than 21 000 cases in the United States. Ophthalmology. 2016;123(4):723–8.
U.S. Department of Health and Human Services CfMaMS. Medicare program; Re- visions to payment policies under the physician fee schedule and other revisions to Part B for CY 2016; Proposed rule. Federal Register 2015. 2016;80:41700.
Hafezi F, Randleman JB. PACK-CXL: defining CXL for infectious keratitis. J Refract Surg. 2014;30(7):438–9.
Kling S, Hufschmid FS, Torres-Netto EA, et al. High fluence increases the antibacterial efficacy of PACK cross-linking. Cornea. 2020;39(8):1020–6.
Hayes S, Boote C, Kamma-Lorger CS, et al. Riboflavin/UVA collagen cross-linking-induced changes in normal and keratoconus corneal stroma. PLoS One. 2011;6(8):e22405.
Martins SA, Combs JC, Noguera G, et al. Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci. 2008;49(8):3402–8.
Naseem I, Ahmad M, Hadi SM. Effect of alkylated and intercalated DNA on the generation of superoxide anion by riboflavin. Biosci Rep. 1988;8(5):485–92.
Pileggi G, Wataha JC, Girard M, et al. Blue light-mediated inactivation of Enterococcus faecalis in vitro. Photodiagnosis Photodyn Ther. 2013;10(2):134–40.
Tsugita A, Okada Y, Uehara K. Photosensitized inactivation of ribonucleic acids in the presence of riboflavin. Biochim Biophys Acta. 1965;103(2):360–3.
Richoz O, Kling S, Hoogewoud F, et al. Antibacterial efficacy of accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking (PACK-CXL). J Refract Surg. 2014;30(12):850–4.
Lang PZ, Hafezi NL, Khandelwal SS, Torres-Netto EA, Hafezi F, Randleman JB. Comparative functional outcomes after corneal crosslinking using standard, accelerated, and accelerated with higher total fluence protocols. Cornea. 2019;38(4):433–41.
Richoz O, Hammer A, Tabibian D, Gatzioufas Z, Hafezi F. The Biomechanical effect of corneal collagen cross-linking (cxl) with riboflavin and UV-A is oxygen dependent. Transl Vis Sci Technol. 2013;2(7):6.
Webb JN, Su JP, Scarcelli G. Mechanical outcome of accelerated corneal crosslinking evaluated by Brillouin microscopy. J Cataract Refract Surg. 2017;43(11):1458–63.
Hammer A, Richoz O, Mosquera S, Tabibian D, Hoogewoud F, Hafezi F. Corneal biomechanical properties at different corneal collagen cross-linking (CXL) irradiances. Invest Ophthalmol Vis Sci. 2014;55(5):2881–4.
Hammer A, Richoz O, Tabibian D, Hafezi F. The increase in biomechanical stiffness in corneal collagen cross-linking (CXL) is oxygen dependent. In: Paper presented at 106th general assembly of the Swiss Ophthalmological Society; August 28–31, 2013, 2013; Locarno, Switzerland.
Torres-Netto EA, Kling S, Hafezi N, Vinciguerra P, Randleman JB, Hafezi F. Oxygen diffusion may limit the biomechanical effectiveness of iontophoresis-assisted transepithelial corneal cross-linking. J Refract Surg. 2018;34(11):768–74.
Hammer A, Richoz O, Arba Mosquera S, Tabibian D, Hoogewoud F, Hafezi F. Corneal biomechanical properties at different corneal cross-linking (CXL) irradiances. Invest Ophthalmol Vis Sci. 2014;55(5):2881–4.
Shajari M, Kolb CM, Agha B, et al. Comparison of standard and accelerated corneal cross-linking for the treatment of keratoconus: a meta-analysis. Acta Ophthalmol. 2019;97(1):e22–35.
Turhan SA, Yargi B, Toker E. Efficacy of conventional versus accelerated corneal cross-linking in pediatric keratoconus: two-year outcomes. J Refract Surg. 2020;36(4):265–9.
Salmon B, Richoz O, Tabibian D, Kling S, Wuarin R, Hafezi F. CXL at the slit lamp: no clinically relevant changes in corneal riboflavin distribution during upright UV irradiation. J Refract Surg. 2017;33(4):281.
Whitcher JP, Srinivasan M. Corneal ulceration in the developing world–a silent epidemic. Br J Ophthalmol. 1997;81(8):622–3.
World Health Organization. Antimicrobial resistance: global report on surveillance. http://www.who.int/drugresistance/documents/surveillancereport/en/. Published 2014. Accessed 29 Oct 2020.
Wei A, Wang K, Wang Y, Gong L, Xu J, Shao T. Evaluation of corneal cross-linking as adjuvant therapy for the management of fungal keratitis. Graefes Arch Clin Exp Ophthalmol. 2019;257(7):1443–52.
Knyazer B, Krakauer Y, Tailakh MA, et al. Accelerated corneal cross-linking as an adjunct therapy in the management of presumed bacterial keratitis: a cohort study. J Refract Surg. 2020;36(4):258–64.
Bonzano C, Di Zazzo A, Barabino S, Coco G, Traverso CE. Collagen cross-linking in the management of microbial keratitis. Ocul Immunol Inflamm. 2019;27(3):507–12.
Price MO, Price FW Jr. Corneal cross-linking in the treatment of corneal ulcers. Curr Opin Ophthalmol. 2016;27(3):250–5.
Knyazer B, Krakauer Y, Baumfeld Y, Lifshitz T, Kling S, Hafezi F. Accelerated corneal cross-linking with photoactivated chromophore for moderate therapy-resistant infectious keratitis. Cornea. 2018;37(4):528–31.
Kling S, Hufschmid FS, Torres-Netto EA, et al. High fluence increases the antibacterial efficacy of PACK cross-linking. Cornea. 2020;39(8):1020-26.
Hafezi F, Torres-Netto EA, Hillen MJP. Re: Prajna et al.: Cross-Linking-Assisted Infection Reduction: a randomized clinical trial evaluating the effect of adjuvant cross-linking on outcomes in fungal keratitis (Ophthalmology. 2020;127:159–66). Ophthalmology. 2021;128(1):e6.
Uysal BS, Yaman D, Sarac O, Akcay E, Cagil N. Sterile keratitis after uneventful corneal collagen cross-linking in a patient with Axenfeld-Rieger syndrome. Int Ophthalmol. 2019;39(5):1169–73.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Torres-Netto, E.A., Hosny, M., Hafezi, F. (2022). Corneal Cross-Linking at the Slit Lamp. In: Armia, A., Mazzotta, C. (eds) Keratoconus. Springer, Cham. https://doi.org/10.1007/978-3-030-84506-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-84506-3_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-84505-6
Online ISBN: 978-3-030-84506-3
eBook Packages: MedicineMedicine (R0)